It is possible that in APOE4 carriers the genetic risk conferred by APOE4 is the stronger force in driving AD pathophysiology, whereas gut permeability may be a more critical factor in individuals with the APOE3/E3 genotype. The gene discussed is APOE; the disease is Alzheimer disease.